Scleroderma Registry & Repository at the Hospital for Special Surgery
ConditionScleroderma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital for Special Surgery, New York
About this trial
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Individuals older than 18 years of age with Scleroderma
Disqualifiers
Individuals younger than 18 years of age
Individuals older than 18 years of age without Scleroderma
Trial population
All individuals older than 18 years of age who have Scleroderma
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: Patients with Scleroderma
Trial outcomes
Primary outcomes
1
Modified Rodnan Skin Score
Physician score of skin thickening over 17 areas of the body.
Time frame
Baseline & follow-up visits during regularly scheduled appointments for up to 5 yearsSecondary outcomes
1
Scleroderma Health Assessment Questionnaire
Patient questionnaire
Time frame
Baseline & follow-up visits during regularly scheduled appointments for up to 5 years2
Short Form-36
Patient questionnaire
Time frame
Baseline & follow-up visits during regularly scheduled appointments for up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov